Inventor · disambiguated record
Haichun Huang
Also filed as: HUANG HAICHUN
80 granted patents·42 pending applications·4,818 citations·filing 2003–2023
99Inventor score
Files withBRISTOL MYERS SQUIBB CO26AMGEN INC18SQUIBB & SONS LLC17PFIZER11NOVAROCK BIOTHERAPEUTICS LTD10
Top patents by PatentIndex Score
122 records- 0199US10441655B2Monoclonal antibodies to programmed death 1 (PD-1)SQUIBB & SONS LLC·Filed 2016·Granted Oct 15, 2019·25 cites·22 claims
- 0299US9580507B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2016·Granted Feb 28, 2017·129 cites·30 claims
- 0399US9492539B2Monoclonal antibodies to Programmed Death 1 (PD-1)SQUIBB & SONS LLC·Filed 2014·Granted Nov 15, 2016·119 cites·65 claims
- 0499US9492540B2Methods for treating cancer using anti-PD-1 antibodiesSQUIBB & SONS LLC·Filed 2014·Granted Nov 15, 2016·139 cites·79 claims
- 0599US9387247B2Monoclonal antibodies to programmed death 1 (PD-1)SQUIBB & SONS LLC·Filed 2014·Granted Jul 12, 2016·124 cites·45 claims
- 0699US9358289B2Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodiesSQUIBB & SONS LLC·Filed 2014·Granted Jun 7, 2016·137 cites·49 claims
- 0799US9273135B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2015·Granted Mar 1, 2016·109 cites·30 claims
- 0899US9102725B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2013·Granted Aug 11, 2015·120 cites·31 claims
- 0999US8383796B2Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2011·Granted Feb 26, 2013·355 cites·31 claims
- 1099US7943743B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)MEDAREX INC·Filed 2006·Granted May 17, 2011·1.5k cites·26 claims
- 1198US9580505B2Human monoclonal antibodies to programmed death ligand 1 (PD-L1)SQUIBB & SONS LLC·Filed 2015·Granted Feb 28, 2017·37 cites·41 claims
- 1298US9228016B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 5, 2016·85 cites·19 claims
- 1398US9084776B2Methods for treating cancer using anti-PD-1 antibodiesMEDAREX LLC·Filed 2014·Granted Jul 21, 2015·203 cites·9 claims
- 1498US8779105B2Monoclonal antibodies to programmed death 1 (PD-1)KORMAN ALAN J·Filed 2011·Granted Jul 15, 2014·479 cites·30 claims
- 1597US10501550B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 10, 2019·9 cites·58 claims
- 1697US10465010B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 5, 2019·9 cites·15 claims
- 1797US9745379B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 29, 2017·11 cites·58 claims
- 1897US9605080B2Antibodies against CD73BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 28, 2017·31 cites·30 claims
- 1997US7960515B2Binding molecules to the human OX40 receptorBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 14, 2011·205 cites·12 claims
- 2096US10100129B2Antibodies against CD73 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 16, 2018·24 cites·35 claims
- 2196US8609816B2Human monoclonal antibodies to O8EKORMAN ALAN J·Filed 2006·Granted Dec 17, 2013·42 cites·26 claims
- 2296US8236930B2Binding molecules to the human OX40 receptorMIN JING·Filed 2011·Granted Aug 7, 2012·85 cites·5 claims
- 2396US7795413B2Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsAMGEN INC·Filed 2007·Granted Sep 14, 2010·55 cites·9 claims
- 2495US9028824B2Binding molecules to the human OX40 receptorMIN JING·Filed 2012·Granted May 12, 2015·75 cites·22 claims
- 2595US8106167B2Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsWILD JR KENNETH D·Filed 2010·Granted Jan 31, 2012·54 cites·8 claims
- 2694US11084881B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 10, 2021·3 cites·19 claims
- 2794US7868140B2Human anti-B7RP1 neutralizing antibodiesAMGEN INC·Filed 2006·Granted Jan 11, 2011·33 cites·39 claims
- 2894US7790859B2Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitorsAMGEN INC·Filed 2007·Granted Sep 7, 2010·24 cites·29 claims
- 2994US7601818B2Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsAMGEN INC·Filed 2004·Granted Oct 13, 2009·72 cites·26 claims
- 3094US7438910B2Therapeutic human anti-IL1-R1 monoclonal antibodyAMGEN INC·Filed 2003·Granted Oct 21, 2008·54 cites·34 claims
- 3193US11213586B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 4, 2022·5 cites·14 claims
- 3293US9683998B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2014·Granted Jun 20, 2017·32 cites·13 claims
- 3393US8124738B2Human monoclonal antibodies to CD70TERRET JONATHAN ALEXANDER·Filed 2006·Granted Feb 28, 2012·102 cites·22 claims
- 3493US7335743B2Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitorsAMGEN INC·Filed 2003·Granted Feb 26, 2008·45 cites·17 claims
- 3592US11407828B2Anti-CLauDiN 18 antibodies and methods of use thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2020·Granted Aug 9, 2022·3 cites·5 claims
- 3692US10690674B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·5 cites·27 claims
- 3792US8258266B2IP-10 antibodies and their usesDESHPANDE SHRIKANT·Filed 2009·Granted Sep 4, 2012·28 cites·17 claims
- 3892US8097703B2CD19 antibodies and their usesRAO-NAIK CHETANA·Filed 2006·Granted Jan 17, 2012·71 cites·20 claims
- 3992US7718776B2Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitorsAMGEN INC·Filed 2003·Granted May 18, 2010·47 cites·50 claims
- 4091US9296822B2Human monoclonal antibodies to O8ESQUIBB & SONS LLC·Filed 2013·Granted Mar 29, 2016·15 cites·26 claims
- 4191US8198410B2Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitorsWILD JR KENNETH D·Filed 2008·Granted Jun 12, 2012·19 cites·12 claims
- 4290US11474112B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2019·Granted Oct 18, 2022·4 cites·27 claims
- 4390US10167343B2Antibodies against CD73BRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·3 cites·34 claims
- 4490US8680247B2Monoclonal antibodies against glypican-3TERRETT JONATHAN ALEXANDER·Filed 2008·Granted Mar 25, 2014·23 cites·21 claims
- 4589US8529902B2Human monoclonal antibodies against CD20TEELING JESSICA·Filed 2003·Granted Sep 10, 2013·36 cites·5 claims
- 4688US2024158524A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4786US2023272079A1Monoclonal Antibodies to Programmed Death 1 (PD-1)SQUIBB & SONS LLC·Filed 2023·Application pending·0 cites
- 4884US11408889B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 9, 2022·1 cites·20 claims
- 4983US11242393B2Antibodies against MICA and/or MICB and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 8, 2022·3 cites·19 claims
- 5082US8039596B2Alpha 5-beta 1 antibodies and their usesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 18, 2011·4 cites·10 claims
Showing the top 50 of 122 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Haichun Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →